Ghost Tree Capital as of June 30, 2022
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 31 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 17.4 | $33M | 450k | 74.28 | |
| Celldex Therapeutics Com New Call Option (CLDX) | 5.6 | $11M | 400k | 26.96 | |
| Amicus Therapeutics (FOLD) | 5.6 | $11M | 1.0M | 10.74 | |
| Apellis Pharmaceuticals (APLS) | 5.3 | $10M | 225k | 45.22 | |
| Sarepta Therapeutics (SRPT) | 5.1 | $9.7M | 130k | 74.96 | |
| Axsome Therapeutics (AXSM) | 4.5 | $8.6M | 225k | 38.30 | |
| Cogent Biosciences (COGT) | 4.2 | $8.1M | 900k | 9.02 | |
| Horizon Therapeutics Pub L SHS | 4.2 | $8.0M | 100k | 79.76 | |
| Mirati Therapeutics | 3.8 | $7.4M | 110k | 67.13 | |
| Vaxcyte (PCVX) | 3.7 | $7.1M | 325k | 21.76 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.6 | $7.0M | 75k | 92.96 | |
| Miragen Therapeutics (VRDN) | 3.6 | $6.9M | 600k | 11.57 | |
| Seagen | 3.2 | $6.2M | 35k | 176.94 | |
| Karuna Therapeutics Ord | 3.0 | $5.7M | 45k | 126.51 | |
| Merus N V (MRUS) | 2.9 | $5.7M | 250k | 22.64 | |
| Iveric Bio | 2.5 | $4.8M | 500k | 9.62 | |
| Cti Biopharma | 2.5 | $4.8M | 800k | 5.97 | |
| Relmada Therapeutics (RLMD) | 2.5 | $4.7M | 250k | 18.99 | |
| Arvinas Ord (ARVN) | 2.4 | $4.6M | 110k | 42.09 | |
| Syndax Pharmaceuticals (SNDX) | 2.3 | $4.3M | 225k | 19.24 | |
| Design Therapeutics (DSGN) | 2.0 | $3.9M | 275k | 14.00 | |
| Kezar Life Sciences | 1.9 | $3.7M | 450k | 8.27 | |
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $3.4M | 325k | 10.58 | |
| Rapt Therapeutics (RAPT) | 1.6 | $3.0M | 165k | 18.25 | |
| Dice Therapeutics | 1.5 | $2.8M | 180k | 15.53 | |
| Aadi Bioscience (AADI) | 1.0 | $1.8M | 150k | 12.32 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $1.8M | 120k | 14.60 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.8 | $1.6M | 300k | 5.25 | |
| 9 Meters Biopharma | 0.2 | $469k | 1.8M | 0.26 | |
| Aeglea Biotherapeutics | 0.2 | $467k | 925k | 0.50 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $277k | 1.9k | 145.79 |
